DNM1L and cancer: Although Drp1 phosphorylation (Ser616) may be involved in chemoresistance, high Drp1 phosphorylation triggered by ERK can activate autophagy through the receptor advanced glycation end product (RAGE)/ERK1/2 pathway, resulting in chemoresistance and regeneration of cancer cells [41].